Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A4TF
|
|||
Former ID |
DNC013543
|
|||
Drug Name |
XR-9544
|
|||
Synonyms |
XR-9544; CHEMBL444075; SCHEMBL14290581; BDBM50375811
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C36H34N4O4
|
|||
Canonical SMILES |
COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC
|
|||
InChI |
1S/C36H34N4O4/c1-43-33-20-25-16-18-40(23-28(25)21-34(33)44-2)17-15-24-11-13-29(14-12-24)38-36(42)30-8-4-6-10-32(30)39-35(41)27-19-26-7-3-5-9-31(26)37-22-27/h3-14,19-22H,15-18,23H2,1-2H3,(H,38,42)(H,39,41)
|
|||
InChIKey |
TZASTBIDWCFCGN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Multidrug resistance protein 1 (ABCB1) | Target Info | Inhibitor | [1] |
Multidrug resistance-associated protein 1 (ABCC1) | Target Info | Inhibitor | [1] | |
KEGG Pathway | ABC transporters | |||
Bile secretion | ||||
MicroRNAs in cancer | ||||
Sphingolipid signaling pathway | ||||
Vitamin digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | |||
TCR Signaling Pathway | ||||
IL6 Signaling Pathway | ||||
Pathway Interaction Database | HIF-1-alpha transcription factor network | |||
S1P1 pathway | ||||
Sphingosine 1-phosphate (S1P) pathway | ||||
Reactome | ABC-family proteins mediated transport | |||
Cobalamin (Cbl, vitamin B12) transport and metabolism | ||||
WikiPathways | Nuclear Receptors in Lipid Metabolism and Toxicity | |||
Abacavir transport and metabolism | ||||
Multi Drug Resistance Protein 1 (Glycoprotein 1) Regulation | ||||
Integrated Pancreatic Cancer Pathway | ||||
Allograft Rejection | ||||
Drug Induction of Bile Acid Pathway | ||||
Codeine and Morphine Metabolism | ||||
Arachidonic acid metabolism | ||||
Irinotecan Pathway | ||||
Metabolism of water-soluble vitamins and cofactors |
References | Top | |||
---|---|---|---|---|
REF 1 | Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors. Bioorg Med Chem. 2008 Mar 1;16(5):2448-62. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.